# Clinical Study of Smoke-Break Liquid Cigarettes

> **NCT00715871** · PHASE2 · COMPLETED · sponsor: **Smoke-Break, Inc.** · enrollment: 52 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** Nicotine
- **DEVICE:** Smoke-Break nicotine delivery device

## Key facts

- **NCT ID:** NCT00715871
- **Lead sponsor:** Smoke-Break, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2014-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00715871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00715871, "Clinical Study of Smoke-Break Liquid Cigarettes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00715871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
